A Phase I Dose Finding and Safety Study of Oral LDE225 in Children and a Phase II Portion to Assess Preliminary Efficacy in Recurrent or Refractory MB
Clinical trial NCT01125800 · COMPLETED
Trial details
- NCT number
- NCT01125800
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-02-01
- Primary completion
- 2014-10-01
- Enrollment
- 76
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.